Amplicon details |
||
Amplicon: |
215 bp | |
1 ctcaccttgc tcctgccgag aaagtatcca tcatggctga tgcaatgcgg 51 cggctgcata cgcttgatcc ggctacctgc ccattcgacc accaagcgaa 101 acatcgcatc gagcgagcac gtactcggat ggaagccggt cttgtcgatc 151 aggatgatct ggacgaagag catcaggggc tcgcgccagc cgaactgttc 201 gccaggctca aggcg |
Record ID | Database | Record description | Record length | Taxon | Method | Amplicon size | Match details |
---|---|---|---|---|---|---|---|
LZ099022.1 | emblrelpat | JP 2017121247-A/47: Isoprene syntha... | 11386 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LZ099205.1 | emblrelpat | JP 2017123856-A/20: COMPOSITIONS AN... | 8804 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LZ099218.1 | emblrelpat | JP 2017123856-A/33: COMPOSITIONS AN... | 10992 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LZ099235.1 | emblrelpat | JP 2017123856-A/50: COMPOSITIONS AN... | 6912 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LZ099236.1 | emblrelpat | JP 2017123856-A/51: COMPOSITIONS AN... | 7902 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
MO933606.1 | emblrelpat | Sequence 10 from patent US 10582702. | 7473 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
MO935232.1 | emblrelpat | Sequence 56 from patent US 10584317. | 5904 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
LZ100809.1 | emblrelpat | JP 2017516839-A/51: HYBRID IMMUNOGL... | 824 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LZ100810.1 | emblrelpat | JP 2017516839-A/52: HYBRID IMMUNOGL... | 6739 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LZ100811.1 | emblrelpat | JP 2017516839-A/53: HYBRID IMMUNOGL... | 6103 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LZ177956.1 | emblrelpat | JP 2017140019-A/24: PRODUCTION OF T... | 1568 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LZ180351.1 | emblrelpat | JP 2017131227-A/2: FUMARYLACETOACET... | 4657 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LZ186239.1 | emblrelpat | JP 2017141261-A/2: THERAPEUTIC COMP... | 5484 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LZ186240.1 | emblrelpat | JP 2017141261-A/3: THERAPEUTIC COMP... | 7051 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LZ186241.1 | emblrelpat | JP 2017141261-A/4: THERAPEUTIC COMP... | 7340 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LZ186243.1 | emblrelpat | JP 2017141261-A/6: THERAPEUTIC COMP... | 7253 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LZ186244.1 | emblrelpat | JP 2017141261-A/7: THERAPEUTIC COMP... | 6398 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LZ186245.1 | emblrelpat | JP 2017141261-A/8: THERAPEUTIC COMP... | 6326 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LZ186246.1 | emblrelpat | JP 2017141261-A/9: THERAPEUTIC COMP... | 6517 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LZ186247.1 | emblrelpat | JP 2017141261-A/10: THERAPEUTIC COM... | 7965 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
Related publications:
Petrillo, M., et al. “JRC GMO-Amplicons: A Collection of Nucleic Acid Sequences Related to Genetically Modified Organisms.” Database (Oxford), vol. 2015 bav101, 30 Sep. 2015, doi:10.1093/database/bav101.
Angers-Loustau, A., et al. “Using the EURL GMFF Online Bioinformatics Resources: A how-to Guide for Practical JRC GMO-Matrix and JRC GMO-Amplicons Case Uses.” European Commission, Ispra, JRC101853, 2016.